fluconazole has been researched along with Tinea Capitis in 44 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Tinea Capitis: Ringworm of the scalp and associated hair mainly caused by species of MICROSPORUM; TRICHOPHYTON; and EPIDERMOPHYTON, which may occasionally involve the eyebrows and eyelashes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the efficacy and safety of fluconazole and griseofulvin in the treatment of tinea capitis." | 9.17 | Treatment of tinea capitis - griseofulvin versus fluconazole - a comparative study. ( Amichai, B; Davidovici, B; Grunwald, MH; Magun, R; Plotnik, IB; Shemer, A, 2013) |
| "Fluconazole constitutes an alternative but, because of greater availability and lower cost, griseofulvin remains the treatment of choice for tinea capitis." | 9.11 | Therapeutic options for the treatment of tinea capitis: griseofulvin versus fluconazole. ( Azizzadeh, M; Dastghaib, L; Jafari, P, 2005) |
| "We sought to assess the efficacy, safety, and optimal dose and duration of fluconazole therapy compared with standard-dose griseofulvin (11 mg/kg per day microsize formulation) in the treatment of pediatric tinea capitis." | 9.11 | A randomized controlled trial assessing the efficacy of fluconazole in the treatment of pediatric tinea capitis. ( Elewski, BE; Foster, KW; Friedlander, SF; Ghannoum, MA; Panzer, H, 2005) |
| "We have demonstrated in an open multicentre investigation that oral fluconazole 6 mg/kg daily for 2 weeks, followed, if clinically indicated four weeks from the start of therapy, by an extra week of treatment at the same dosage, may be effective and safe in the treatment of tinea capitis." | 9.09 | Intermittent short duration therapy with fluconazole is effective for tinea capitis. ( Aboobaker, J; Adam, P; Dlova, N; Gupta, AK; Hofstader, SL; Konnikov, N; Lynde, CW; Morar, N; Raboobee, N; Summerbell, RC; Taborda, P; Taborda, V, 1999) |
| "In an open, multicentre evaluation carried out in Brazil, Canada and South Africa we have demonstrated that fluconazole 8 mg kg-1 once weekly is effective in tinea capitis caused by Trichophyton and Microsporum species." | 9.09 | Once weekly fluconazole is effective in children in the treatment of tinea capitis: a prospective, multicentre study. ( Aboobaker, J; Adam, P; Borges, M; Dlova, N; Gupta, AK; Hofstader, SL; Konnikov, N; Lynde, CW; Morar, N; Raboobee, N; Summerbell, RC; Taborda, P; Taborda, V, 2000) |
| " This study is aimed to detect the antifungal activity of silver nanoparticles (SNPs) on Fluconazole resistant dermatophytes isolated from primary school children clinically suffering from tinea capitis and attending El-Sheikh Zaid Dermatology Center in Ismailia." | 7.85 | Antifungal activity of silver nanoparticles on Fluconazole resistant Dermatophytes identified by (GACA)4 and isolated from primary school children suffering from Tinea Capitis in Ismailia - Egypt. ( Abdalla, S; Amin, ME; Azab, MM; Hanora, AM, 2017) |
| "In this study, the voriconazole susceptibilities of dermatophyte isolates obtained from a worldwide tinea capitis trial were compared to their susceptibilities to fluconazole and griseofulvin." | 7.73 | Voriconazole susceptibilities of dermatophyte isolates obtained from a worldwide tinea capitis clinical trial. ( Ghannoum, M; Isham, N; Sheehan, D, 2006) |
| " However, varying dosage schedules, changes in epidemiology, and rising drug resistance are factors that hamper treatment in some cases." | 6.77 | Comparative evaluation of griseofulvin, terbinafine and fluconazole in the treatment of tinea capitis. ( Arora, P; Grover, C; Manchanda, V, 2012) |
| "Tinea capitis is the most common dermatophyte infection during childhood." | 6.41 | [Tinea capitis. Therapeutic options in the post-griseofulvin era]. ( Abeck, D; Korting, HC; Möhrenschlager, M; Ring, J; Seidl, HP, 2002) |
| " Short course and pulse dosing are particularly exciting options that may decrease cost and lower the risk of adverse side effects." | 6.40 | The evolving role of itraconazole, fluconazole and terbinafine in the treatment of tinea capitis. ( Friedlander, SF, 1999) |
| "Fluconazole was effective in treating pediatric tinea capitis caused by Microsporum canis and was well tolerated." | 5.31 | Fluconazole in the treatment of pediatric tinea capitis caused by Microsporum canis. ( Iordanidou, A; Pangalis, A; Raftopoulou, A; Valari, M, 2002) |
| "To compare the efficacy and safety of fluconazole and griseofulvin in the treatment of tinea capitis." | 5.17 | Treatment of tinea capitis - griseofulvin versus fluconazole - a comparative study. ( Amichai, B; Davidovici, B; Grunwald, MH; Magun, R; Plotnik, IB; Shemer, A, 2013) |
| "Fluconazole constitutes an alternative but, because of greater availability and lower cost, griseofulvin remains the treatment of choice for tinea capitis." | 5.11 | Therapeutic options for the treatment of tinea capitis: griseofulvin versus fluconazole. ( Azizzadeh, M; Dastghaib, L; Jafari, P, 2005) |
| "We sought to assess the efficacy, safety, and optimal dose and duration of fluconazole therapy compared with standard-dose griseofulvin (11 mg/kg per day microsize formulation) in the treatment of pediatric tinea capitis." | 5.11 | A randomized controlled trial assessing the efficacy of fluconazole in the treatment of pediatric tinea capitis. ( Elewski, BE; Foster, KW; Friedlander, SF; Ghannoum, MA; Panzer, H, 2005) |
| "We have demonstrated in an open multicentre investigation that oral fluconazole 6 mg/kg daily for 2 weeks, followed, if clinically indicated four weeks from the start of therapy, by an extra week of treatment at the same dosage, may be effective and safe in the treatment of tinea capitis." | 5.09 | Intermittent short duration therapy with fluconazole is effective for tinea capitis. ( Aboobaker, J; Adam, P; Dlova, N; Gupta, AK; Hofstader, SL; Konnikov, N; Lynde, CW; Morar, N; Raboobee, N; Summerbell, RC; Taborda, P; Taborda, V, 1999) |
| "In an open, multicentre evaluation carried out in Brazil, Canada and South Africa we have demonstrated that fluconazole 8 mg kg-1 once weekly is effective in tinea capitis caused by Trichophyton and Microsporum species." | 5.09 | Once weekly fluconazole is effective in children in the treatment of tinea capitis: a prospective, multicentre study. ( Aboobaker, J; Adam, P; Borges, M; Dlova, N; Gupta, AK; Hofstader, SL; Konnikov, N; Lynde, CW; Morar, N; Raboobee, N; Summerbell, RC; Taborda, P; Taborda, V, 2000) |
| "Newer treatments including terbinafine, itraconazole and fluconazole are at least similar to griseofulvin in children with tinea capitis caused by Trichophyton species." | 4.93 | Systemic antifungal therapy for tinea capitis in children. ( Bennett, C; Chen, X; González, U; Hua, X; Jiang, X; Lin, X; Xue, S; Yang, M; Zhang, M, 2016) |
| "The best evidence suggests that newer treatments including terbinafine, itraconazole and fluconazole may be similar to griseofulvin in children with tinea capitis caused by Trichophyton species." | 4.84 | Systemic antifungal therapy for tinea capitis in children. ( Bergus, G; González, U; Jacobson, J; Martínez-Monzón, C; Seaton, T, 2007) |
| "Currently, many experts consider griseofulvin to be the drug of choice for tinea capitis." | 4.82 | Tinea capitis: a treatment update. ( Friedlander, SF; Roberts, BJ, 2005) |
| "Currently, many experts consider griseofulvin to be the drug of choice for tinea capitis." | 4.82 | New treatments for tinea capitis. ( Chan, YC; Friedlander, SF, 2004) |
| "To determine the epidemiological profile of dermatophytes among patients of tinea capitis and their susceptibility pattern to fluconazole and terbinafine." | 4.31 | The rising menace of antifungal resistance in dermatophytes among the patients of tinea capitis. ( Sabir, M; Uddin, F; Zeeshan, F, 2023) |
| " In conclusion, we recommend to relate to scaly scalp in high-risk populations as Tinea capitis, and to treat with griseofulvin at a dosage of up to 50 mg/kg/day, starting from the first presentation to the pediatrician." | 4.02 | Tinea capitis in an immigrant pediatric community; a clinical signs-based treatment approach. ( Azrad, M; Kassem, R; Nitzan, O; Peretz, A; Shemesh, Y, 2021) |
| " This study is aimed to detect the antifungal activity of silver nanoparticles (SNPs) on Fluconazole resistant dermatophytes isolated from primary school children clinically suffering from tinea capitis and attending El-Sheikh Zaid Dermatology Center in Ismailia." | 3.85 | Antifungal activity of silver nanoparticles on Fluconazole resistant Dermatophytes identified by (GACA)4 and isolated from primary school children suffering from Tinea Capitis in Ismailia - Egypt. ( Abdalla, S; Amin, ME; Azab, MM; Hanora, AM, 2017) |
| " Because of the clinical and molecular diagnosis of tinea capitis, oral antifungal therapy with fluconazole 5 mg kg(-1) body weight was started, along with cotrimoxazole and fosfomycin for the cMRSA." | 3.78 | [Tinea capitis profunda due to Trichophyton verrucosum with cMRSA superinfection in an infant]. ( Blömer, RH; Faber, A; Gräser, Y; Keilani, N; Krüger, C; Nenoff, P; Rodeck, B; Uhrlaß, S, 2012) |
| "In this study, the voriconazole susceptibilities of dermatophyte isolates obtained from a worldwide tinea capitis trial were compared to their susceptibilities to fluconazole and griseofulvin." | 3.73 | Voriconazole susceptibilities of dermatophyte isolates obtained from a worldwide tinea capitis clinical trial. ( Ghannoum, M; Isham, N; Sheehan, D, 2006) |
| " However, varying dosage schedules, changes in epidemiology, and rising drug resistance are factors that hamper treatment in some cases." | 2.77 | Comparative evaluation of griseofulvin, terbinafine and fluconazole in the treatment of tinea capitis. ( Arora, P; Grover, C; Manchanda, V, 2012) |
| "Tinea capitis is the most common cutaneous fungal infection in children." | 2.58 | Tinea capitis in children: a systematic review of management. ( Friedlander, SF; Gupta, AK; Mays, RR; Piguet, V; Piraccini, BM; Shear, NH; Tosti, A; Versteeg, SG, 2018) |
| "Tinea capitis is an infection of the scalp and hair shaft caused by dermatophyte fungi." | 2.44 | The assessment and management of tinea capitis in children. ( Ali, S; Forgie, SE; Graham, TA, 2007) |
| "Fluconazole has excellent absorption and good persistence in tissues that suggests it may be useful in superficial fungal infections." | 2.42 | The use of fluconazole to treat superficial fungal infections in children. ( Cooper, EA; Gupta, AK; Montero-Gei, F, 2003) |
| "Tinea capitis is the most common dermatophyte infection during childhood." | 2.41 | [Tinea capitis. Therapeutic options in the post-griseofulvin era]. ( Abeck, D; Korting, HC; Möhrenschlager, M; Ring, J; Seidl, HP, 2002) |
| "Important advances in the diagnosis and treatment of tinea capitis include a renewed interest in the use of the cotton swab method of diagnosing fungal cultures in children, and the ongoing investigation of promising new medications for the treatment of tinea capitis, including terbinafine, itraconazole, and fluconazole in this era of resistant organisms." | 2.41 | Tinea capitis update: a continuing conflict with an old adversary. ( Chen, BK; Friedlander, SF, 2001) |
| "Tinea capitis is a common dermatophyte infection of the scalp in children." | 2.41 | Tinea capitis. ( Gupta, AK; Summerbell, RC, 2000) |
| " Short course and pulse dosing are particularly exciting options that may decrease cost and lower the risk of adverse side effects." | 2.40 | The evolving role of itraconazole, fluconazole and terbinafine in the treatment of tinea capitis. ( Friedlander, SF, 1999) |
| "The majority of providers treated tinea capitis with the oral antifungal agent griseofulvin and did not obtain a fungal culture." | 1.62 | A Retrospective Study of Tinea Capitis Management in General Pediatric Clinics and Pediatric Emergency Departments at 2 US Centers. ( Cohen, BA; DiBiagio, JR; Goldenberg, NA; Le, TK; Woodard, AA, 2021) |
| " Response rates to griseofulvin are similar to rates seen in the 1970s, but require higher dosing and conversion to crushed tablets in partial responders." | 1.38 | Treatment outcomes for tinea capitis in a skin of color population. ( Alexis, A; Bhanusali, D; Coley, M; Silverberg, JI; Silverberg, NB, 2012) |
| "Sertaconazole was active against 114 isolates of 12 fungal dermatophyte species, showing an overall geometric mean of 0." | 1.32 | In vitro activity of sertaconazole against dermatophyte isolates with reduced fluconazole susceptibility. ( Cárdenes, DC; Carrillo-Muñoz, AJ; Fernández-Torres, B; Guarro, J, 2003) |
| "Fluconazole was effective in treating pediatric tinea capitis caused by Microsporum canis and was well tolerated." | 1.31 | Fluconazole in the treatment of pediatric tinea capitis caused by Microsporum canis. ( Iordanidou, A; Pangalis, A; Raftopoulou, A; Valari, M, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (9.09) | 18.2507 |
| 2000's | 21 (47.73) | 29.6817 |
| 2010's | 13 (29.55) | 24.3611 |
| 2020's | 6 (13.64) | 2.80 |
| Authors | Studies |
|---|---|
| Gold, JAW | 1 |
| Benedict, K | 1 |
| Dulski, TM | 1 |
| Lipner, SR | 1 |
| Zeeshan, F | 1 |
| Sabir, M | 1 |
| Uddin, F | 1 |
| Henkel, E | 1 |
| Buch, C | 1 |
| Bambekova, P | 1 |
| Usatine, RP | 1 |
| Woodard, AA | 1 |
| Le, TK | 2 |
| DiBiagio, JR | 1 |
| Goldenberg, NA | 1 |
| Cohen, BA | 2 |
| Kassem, R | 1 |
| Shemesh, Y | 1 |
| Nitzan, O | 1 |
| Azrad, M | 1 |
| Peretz, A | 1 |
| Amin, ME | 1 |
| Azab, MM | 1 |
| Hanora, AM | 1 |
| Abdalla, S | 1 |
| Nenoff, P | 2 |
| Krüger, C | 2 |
| Schulze, I | 1 |
| Koch, D | 1 |
| Rahmig, N | 1 |
| Hipler, UC | 1 |
| Uhrlaß, S | 2 |
| Richarz, NA | 1 |
| Barboza, L | 1 |
| Monsonís, M | 1 |
| González-Enseñat, MA | 1 |
| Vicente, A | 1 |
| Gupta, AK | 5 |
| Mays, RR | 1 |
| Versteeg, SG | 1 |
| Piraccini, BM | 2 |
| Shear, NH | 1 |
| Piguet, V | 1 |
| Tosti, A | 2 |
| Friedlander, SF | 6 |
| Shemer, A | 1 |
| Plotnik, IB | 1 |
| Davidovici, B | 1 |
| Grunwald, MH | 1 |
| Magun, R | 1 |
| Amichai, B | 1 |
| Kim, K | 1 |
| Chen, X | 1 |
| Jiang, X | 1 |
| Yang, M | 1 |
| González, U | 2 |
| Lin, X | 1 |
| Hua, X | 1 |
| Xue, S | 1 |
| Zhang, M | 1 |
| Bennett, C | 1 |
| Zampella, JG | 1 |
| Kwatra, SG | 1 |
| Blanck, J | 1 |
| Cohen, B | 1 |
| Tangjaturonrusamee, C | 1 |
| Vincenzi, C | 1 |
| Starace, M | 1 |
| Kopel, E | 1 |
| Amitai, Z | 1 |
| Sprecher, H | 1 |
| Predescu, S | 1 |
| Kaliner, E | 1 |
| Volovik, I | 1 |
| Blömer, RH | 1 |
| Keilani, N | 1 |
| Faber, A | 1 |
| Rodeck, B | 1 |
| Gräser, Y | 1 |
| Grover, C | 1 |
| Arora, P | 1 |
| Manchanda, V | 1 |
| Bhanusali, D | 1 |
| Coley, M | 1 |
| Silverberg, JI | 1 |
| Alexis, A | 1 |
| Silverberg, NB | 2 |
| Möhrenschlager, M | 1 |
| Korting, HC | 1 |
| Seidl, HP | 1 |
| Ring, J | 1 |
| Abeck, D | 1 |
| Valari, M | 2 |
| Iordanidou, A | 1 |
| Raftopoulou, A | 1 |
| Pangalis, A | 1 |
| Kolivras, A | 1 |
| Lateur, N | 1 |
| De Maubeuge, J | 1 |
| Scheers, C | 1 |
| Wiame, L | 1 |
| Song, M | 1 |
| Springer, K | 1 |
| Brown, M | 1 |
| Stulberg, DL | 1 |
| Bigby, M | 1 |
| Cooper, EA | 1 |
| Montero-Gei, F | 2 |
| Carrillo-Muñoz, AJ | 1 |
| Fernández-Torres, B | 1 |
| Cárdenes, DC | 1 |
| Guarro, J | 1 |
| Chan, YC | 1 |
| Roberts, BJ | 1 |
| Haedersdal, M | 1 |
| Svejgaard, EL | 1 |
| Dastghaib, L | 1 |
| Azizzadeh, M | 1 |
| Jafari, P | 1 |
| Foster, KW | 1 |
| Panzer, H | 1 |
| Ghannoum, MA | 1 |
| Elewski, BE | 1 |
| Ghannoum, M | 1 |
| Isham, N | 1 |
| Sheehan, D | 1 |
| Stefanaki, C | 1 |
| Karteri, G | 1 |
| Zarkadi, E | 1 |
| Katsambas, A | 1 |
| Alvarez, MS | 1 |
| Ali, S | 1 |
| Graham, TA | 1 |
| Forgie, SE | 1 |
| Seaton, T | 1 |
| Bergus, G | 1 |
| Jacobson, J | 1 |
| Martínez-Monzón, C | 1 |
| Méndez-Tovar, LJ | 1 |
| Manzano-Gayosso, P | 1 |
| Velásquez-Hernández, V | 1 |
| Millan-Chiu, B | 1 |
| Hernández-Hernández, F | 1 |
| Mondragón-González, R | 1 |
| López-Martínez, R | 1 |
| Solomon, BA | 1 |
| Collins, R | 1 |
| Sharma, R | 1 |
| Silverberg, N | 1 |
| Jain, AR | 1 |
| Sedgh, J | 1 |
| Laude, TA | 1 |
| Adam, P | 2 |
| Hofstader, SL | 2 |
| Lynde, CW | 2 |
| Taborda, P | 2 |
| Taborda, V | 2 |
| Morar, N | 2 |
| Dlova, N | 2 |
| Raboobee, N | 2 |
| Konnikov, N | 2 |
| Aboobaker, J | 2 |
| Summerbell, RC | 3 |
| Borges, M | 1 |
| Chen, BK | 1 |
16 reviews available for fluconazole and Tinea Capitis
| Article | Year |
|---|---|
Tinea capitis: advances and a needed paradigm shift.
Topics: Antifungal Agents; Arthrodermataceae; Child; Fluconazole; Humans; Itraconazole; Microsporum; Naphtha | 2021 |
[Tinea capitis and onychomycosis due to Trichophyton soudanense : Successful treatment with fluconazole-literature review].
Topics: Antifungal Agents; Child; Dermatomycoses; Europe; Female; Fluconazole; Germany; Humans; Onychomycosi | 2018 |
Tinea capitis in children: a systematic review of management.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Child; Drug Therapy, Combination | 2018 |
Systemic antifungal therapy for tinea capitis in children.
Topics: Antifungal Agents; Child; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalene | 2016 |
Tinea in Tots: Cases and Literature Review of Oral Antifungal Treatment of Tinea Capitis in Children under 2 Years of Age.
Topics: Administration, Oral; Antifungal Agents; Drug Administration Schedule; Female; Fluconazole; Griseofu | 2017 |
[Tinea capitis. Therapeutic options in the post-griseofulvin era].
Topics: Antifungal Agents; Clinical Trials as Topic; Drug Interactions; Fluconazole; Griseofulvin; Humans; I | 2002 |
Common hair loss disorders.
Topics: Alopecia; Antifungal Agents; Diagnosis, Differential; Fluconazole; Humans; Hypotrichosis; Minoxidil; | 2003 |
The use of fluconazole to treat superficial fungal infections in children.
Topics: Administration, Oral; Antifungal Agents; Child; Child Welfare; Drug Administration Schedule; Flucona | 2003 |
New treatments for tinea capitis.
Topics: Administration, Oral; Antifungal Agents; Fluconazole; Griseofulvin; Humans; Itraconazole; Microsporu | 2004 |
Tinea capitis: a treatment update.
Topics: Antifungal Agents; Child; Dose-Response Relationship, Drug; Fluconazole; Griseofulvin; Humans; Itrac | 2005 |
Tinea capitis.
Topics: Antifungal Agents; Fluconazole; Global Health; Griseofulvin; Humans; Itraconazole; Microsporum; Naph | 2006 |
The assessment and management of tinea capitis in children.
Topics: Antifungal Agents; Child; Diagnosis, Differential; Fluconazole; Griseofulvin; Humans; Incidence; Itr | 2007 |
Systemic antifungal therapy for tinea capitis in children.
Topics: Antifungal Agents; Child; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Randomized | 2007 |
The evolving role of itraconazole, fluconazole and terbinafine in the treatment of tinea capitis.
Topics: Antifungal Agents; Child; Fluconazole; Humans; Itraconazole; Naphthalenes; Terbinafine; Tinea Capiti | 1999 |
Tinea capitis.
Topics: Antifungal Agents; Arthrodermataceae; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; | 2000 |
Tinea capitis update: a continuing conflict with an old adversary.
Topics: Antifungal Agents; Child; Child, Preschool; Drug Interactions; Drug Resistance, Fungal; Fluconazole; | 2001 |
9 trials available for fluconazole and Tinea Capitis
| Article | Year |
|---|---|
Treatment of tinea capitis - griseofulvin versus fluconazole - a comparative study.
Topics: Antifungal Agents; Child; Child, Preschool; Female; Fluconazole; Griseofulvin; Humans; Infant; Israe | 2013 |
Comparative evaluation of griseofulvin, terbinafine and fluconazole in the treatment of tinea capitis.
Topics: Antifungal Agents; Child; Cross-Sectional Studies; Female; Fluconazole; Griseofulvin; Humans; Male; | 2012 |
Once-weekly fluconazole in children with tinea capitis due to Microsporum canis.
Topics: Adolescent; Child; Child, Preschool; Denmark; Drug Administration Schedule; Female; Fluconazole; Hum | 2005 |
Therapeutic options for the treatment of tinea capitis: griseofulvin versus fluconazole.
Topics: Administration, Oral; Adolescent; Antifungal Agents; Chi-Square Distribution; Child; Child, Preschoo | 2005 |
A randomized controlled trial assessing the efficacy of fluconazole in the treatment of pediatric tinea capitis.
Topics: Antifungal Agents; Child; Child, Preschool; Female; Fluconazole; Griseofulvin; Humans; Male; Single- | 2005 |
Fluconazole for the treatment of tinea capitis in children.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Female; Fluconazole; Humans; Male; Pilot Pro | 1997 |
Fluconazole in the treatment of tinea capitis.
Topics: Antifungal Agents; Child; Female; Fluconazole; Humans; Male; Microsporum; Tinea Capitis; Treatment O | 1998 |
Intermittent short duration therapy with fluconazole is effective for tinea capitis.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Female; Fluconazole; Humans; Infant; Infant, | 1999 |
Once weekly fluconazole is effective in children in the treatment of tinea capitis: a prospective, multicentre study.
Topics: Antifungal Agents; Child; Child, Preschool; Drug Administration Schedule; Female; Fluconazole; Human | 2000 |
19 other studies available for fluconazole and Tinea Capitis
| Article | Year |
|---|---|
Inadequate diagnostic testing and systemic antifungal prescribing for tinea capitis in an observational cohort study of 3.9 million children, United States.
Topics: Antifungal Agents; Child; Cohort Studies; Fluconazole; Humans; Itraconazole; Terbinafine; Tinea Capi | 2023 |
The rising menace of antifungal resistance in dermatophytes among the patients of tinea capitis.
Topics: Antifungal Agents; Child; Cross-Sectional Studies; Female; Fluconazole; Humans; Male; Terbinafine; T | 2023 |
Itchy scalp with scale.
Topics: Animals; Antifungal Agents; Child; Fluconazole; Humans; Male; Panama; Scalp Dermatoses; Tinea Capiti | 2020 |
A Retrospective Study of Tinea Capitis Management in General Pediatric Clinics and Pediatric Emergency Departments at 2 US Centers.
Topics: Academic Medical Centers; Adolescent; Antifungal Agents; Child; Child, Preschool; Cross-Sectional St | 2021 |
Tinea capitis in an immigrant pediatric community; a clinical signs-based treatment approach.
Topics: Antifungal Agents; Child; Emigrants and Immigrants; Fluconazole; Griseofulvin; Humans; Tinea Capitis | 2021 |
Antifungal activity of silver nanoparticles on Fluconazole resistant Dermatophytes identified by (GACA)4 and isolated from primary school children suffering from Tinea Capitis in Ismailia - Egypt.
Topics: Antifungal Agents; Drug Resistance, Fungal; Egypt; Fluconazole; Humans; Metal Nanoparticles; Polymer | 2017 |
Trichoscopy helps to predict the time point of clinical cure of tinea capitis.
Topics: Alopecia; Dermoscopy; Female; Fluconazole; Follow-Up Studies; Hair; Humans; Infant; Tinea Capitis; T | 2018 |
Inflammatory masses on boy's scalp.
Topics: Antifungal Agents; Child; Erythema Nodosum; Fluconazole; Humans; Male; Tinea Capitis; Treatment Outc | 2015 |
Tinea capitis mimicking folliculitis decalvans.
Topics: Antifungal Agents; Female; Fluconazole; Folliculitis; Humans; Microsporum; Middle Aged; Scalp; Tinea | 2011 |
Tinea capitis outbreak in a paediatric refugee population, Tel Aviv, Israel.
Topics: Antifungal Agents; Child; Child, Preschool; Disease Outbreaks; Female; Fluconazole; Griseofulvin; Hu | 2012 |
[Tinea capitis profunda due to Trichophyton verrucosum with cMRSA superinfection in an infant].
Topics: Antifungal Agents; Child, Preschool; Fluconazole; Humans; Male; Methicillin-Resistant Staphylococcus | 2012 |
Treatment outcomes for tinea capitis in a skin of color population.
Topics: Adolescent; Age Factors; Antifungal Agents; Black or African American; Child; Child, Preschool; Dose | 2012 |
Fluconazole in the treatment of pediatric tinea capitis caused by Microsporum canis.
Topics: Adolescent; Child; Child, Preschool; Female; Fluconazole; Follow-Up Studies; Humans; Male; Microspor | 2002 |
Tinea capitis in Brussels: epidemiology and new management strategy.
Topics: Adolescent; Antifungal Agents; Belgium; Child; Child, Preschool; Drug Combinations; Female; Fluconaz | 2003 |
Newer antifungal agents.
Topics: Antifungal Agents; Fluconazole; Griseofulvin; Humans; Naphthalenes; Terbinafine; Tinea Capitis | 2003 |
In vitro activity of sertaconazole against dermatophyte isolates with reduced fluconazole susceptibility.
Topics: Antifungal Agents; Arthrodermataceae; Drug Resistance, Fungal; Fluconazole; Imidazoles; Microbial Se | 2003 |
Voriconazole susceptibilities of dermatophyte isolates obtained from a worldwide tinea capitis clinical trial.
Topics: Antifungal Agents; Arthrodermataceae; Clinical Trials as Topic; Fluconazole; Griseofulvin; Humans; M | 2006 |
Tinea capitis due to Trichophyton rubrum in a 3-month-old infant.
Topics: Administration, Oral; Antifungal Agents; Female; Fluconazole; Hair; Humans; Infant; Tinea Capitis; T | 2006 |
[Resistance to azolic compounds in clinical Trichophyton spp. strains].
Topics: Adult; Antifungal Agents; Cross Infection; Drug Resistance, Fungal; Drug Resistance, Multiple, Funga | 2007 |